Promising Cancer Cure Hits the Market

This video will focus specifically on CAR T-cell therapy as an immunotherapy for the treatment of leukemia, cancer of the blood… just one of 100 identified cancers.

Immunotherapy is relatively new compared to the three primary pillars of cancer treatment: surgery, chemotherapy, and radiation.

Significant leaps in molecular biology techniques, in particular, have advanced the understanding on how the immune system works, in addition to how it can be modulated.

This has lead the scientific community to identify the chimeric antigen receptor (CAR) as a potential target for molecular genetics to insert new epitopes on the receptor region, allowing a degree of control of the immune system.

This site uses Akismet to reduce spam. Learn how your comment data is processed.